These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 12679467)

  • 21. Recovery of hormone secretion after chronic gonadotropin-releasing hormone agonist administration in women with polycystic ovarian disease.
    de Ziegler D; Steingold K; Cedars M; Lu JK; Meldrum DR; Judd HL; Chang RJ
    J Clin Endocrinol Metab; 1989 Jun; 68(6):1111-7. PubMed ID: 2524501
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mid-follicular phase pulses of inhibin B are absent in polycystic ovarian syndrome and are initiated by successful laparoscopic ovarian diathermy: a possible mechanism regulating emergence of the dominant follicle.
    Lockwood GM; Muttukrishna S; Groome NP; Matthews DR; Ledger WL
    J Clin Endocrinol Metab; 1998 May; 83(5):1730-5. PubMed ID: 9589683
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Specific factors predict the response to pulsatile gonadotropin-releasing hormone therapy in polycystic ovarian syndrome.
    Gill S; Taylor AE; Martin KA; Welt CK; Adams JM; Hall JE
    J Clin Endocrinol Metab; 2001 Jun; 86(6):2428-36. PubMed ID: 11397835
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enhanced stimulation of follicle maturation and ovulatory potential by long acting follicle-stimulating hormone agonists with extended carboxyl-terminal peptides.
    LaPolt PS; Nishimori K; Fares FA; Perlas E; Boime I; Hsueh AJ
    Endocrinology; 1992 Dec; 131(6):2514-20. PubMed ID: 1446593
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Androgen modulation of follicle-stimulating hormone-induced granulosa cell steroidogenesis in the primate ovary.
    Harlow CR; Hillier SG; Hodges JK
    Endocrinology; 1986 Sep; 119(3):1403-5. PubMed ID: 3089768
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increased androgen response to follicle-stimulating hormone administration in women with polycystic ovary syndrome.
    Wachs DS; Coffler MS; Malcom PJ; Shimasaki S; Chang RJ
    J Clin Endocrinol Metab; 2008 May; 93(5):1827-33. PubMed ID: 18285408
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of estradiol on granulosa cell responses to FSH in women with polycystic ovary syndrome.
    Homer MV; Rosencrantz MA; Shayya RF; Chang RJ
    Reprod Biol Endocrinol; 2017 Feb; 15(1):13. PubMed ID: 28187771
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased anti-Müllerian hormone serum concentrations in prepubertal daughters of women with polycystic ovary syndrome.
    Sir-Petermann T; Codner E; Maliqueo M; Echiburú B; Hitschfeld C; Crisosto N; Pérez-Bravo F; Recabarren SE; Cassorla F
    J Clin Endocrinol Metab; 2006 Aug; 91(8):3105-9. PubMed ID: 16720659
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ovarian 17-hydroxyprogesterone hyperresponsiveness to gonadotropin-releasing hormone (GnRH) agonist challenge in women with polycystic ovary syndrome is not mediated by luteinizing hormone hypersecretion: evidence from GnRH agonist and human chorionic gonadotropin stimulation testing.
    Ibañez L; Hall JE; Potau N; Carrascosa A; Prat N; Taylor AE
    J Clin Endocrinol Metab; 1996 Nov; 81(11):4103-7. PubMed ID: 8923867
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vaginal progesterone administration before ovulation induction with exogenous gonadotropins in polycystic ovarian syndrome.
    Buckler HM; Phillips SE; Cameron IT; Healy DL; Burger HG
    J Clin Endocrinol Metab; 1988 Aug; 67(2):300-6. PubMed ID: 3134388
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Insulin, somatotropic, and luteinizing hormone axes in lean and obese women with polycystic ovary syndrome: common and distinct features.
    Morales AJ; Laughlin GA; Bützow T; Maheshwari H; Baumann G; Yen SS
    J Clin Endocrinol Metab; 1996 Aug; 81(8):2854-64. PubMed ID: 8768842
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Factors influencing follicle-stimulating hormone-responsive steroidogenesis in marmoset granulosa cells: effects of androgens and the stage of follicular maturity.
    Harlow CR; Shaw HJ; Hillier SG; Hodges JK
    Endocrinology; 1988 Jun; 122(6):2780-7. PubMed ID: 3131124
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CI628 inhibits follicle-stimulating hormone (FSH)-induced increases in FSH receptors of the rat ovary: requirement of estradiol for FSH action.
    Tonetta SA; Spicer LJ; Ireland JJ
    Endocrinology; 1985 Feb; 116(2):715-22. PubMed ID: 2981676
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vascular endothelial growth factor and basic fibroblast growth factor in polycystic ovary syndrome during controlled ovarian hyperstimulation.
    Artini PG; Monti M; Matteucci C; Valentino V; Cristello F; Genazzani AR
    Gynecol Endocrinol; 2006 Aug; 22(8):465-70. PubMed ID: 17012110
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Low levels of follicle-stimulating hormone receptor-activation inhibitors in serum and follicular fluid from normal controls and anovulatory patients with or without polycystic ovary syndrome.
    Schipper I; Rommerts FF; Ten Hacken PM; Fauser BC
    J Clin Endocrinol Metab; 1997 May; 82(5):1325-31. PubMed ID: 9141511
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Poor ovarian response to gonadotropin stimulation is associated with low expression of follicle-stimulating hormone receptor in granulosa cells.
    Cai J; Lou HY; Dong MY; Lu XE; Zhu YM; Gao HJ; Huang HF
    Fertil Steril; 2007 Jun; 87(6):1350-6. PubMed ID: 17296182
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of low dose human chorionic gonadotropin on follicular response and oocyte maturation in PCOS patients undergoing IVF cycles: a randomized clinical trial of efficacy and safety.
    Ashrafi M; Kiani K; Ghasemi A; Rastegar F; Nabavi M
    Arch Gynecol Obstet; 2011 Dec; 284(6):1431-8. PubMed ID: 21210134
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Plasma level of calcitonin gene-related peptide in patients with polycystic ovary syndrome and its relationship to hormonal and metabolic parameters.
    Zhang Z; Gong F; Lu GX
    Peptides; 2012 Apr; 34(2):343-8. PubMed ID: 22314079
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Does plasma insulin level affect ovarian response to exogenous administration of follicle-stimulating hormone in women without polycystic ovary syndrome?
    La Marca A; Pati M; Giulini S; Levratti P; Caretto S; Volpe A
    Gynecol Endocrinol; 2005 Nov; 21(5):292-4. PubMed ID: 16373249
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inverse relationship between luteinizing hormone and body mass index in polycystic ovarian syndrome: investigation of hypothalamic and pituitary contributions.
    Pagán YL; Srouji SS; Jimenez Y; Emerson A; Gill S; Hall JE
    J Clin Endocrinol Metab; 2006 Apr; 91(4):1309-16. PubMed ID: 16434454
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.